Brief: Promore Pharma Q3 Net Loss at SEK -3.9 Million
Nov 28 (Reuters) - Promore Pharma Q3 EPS SEK -0.06. * Q3 sales SEK 0 * Q3 net income SEK -3.9 million
Recent news on PMD Device Solutions AB
See all newsBrief: PMD Device Solutions Files For Bankruptcy
Brief: PMD Device Solutions Q3 EBITDA Loss Widens To SEK 8.9 Mln
Brief: Pmd Device Solutions Completes Sale Of Coala Life Monitor
Brief: PMDS’ Largest Shareholder Requests EGM To Appoint New Non-Executive Directors
Brief: PMDS Says RespiraSense Technology Demonstrates Capability In Predicting 7-Day Mortality